Satheesh Chonat MD
Associate Professor, Department of Pediatrics, Emory University and Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta
Join to View Full Profile
1405 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-785-1112
Fax+1 404-785-6288
Dr. Chonat is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015
University of Michigan Health - Sparrow/Michigan State UniversityResidency, Pediatrics, 2009 - 2012- Cambridge University Hospitals and London School of PaediatricsSpeciality Training Registrar, General Pediatrics, Neonatology and Hematology/Oncology, 2003 - 2009
M.S. Ramaiah Medical CollegeClass of 2003
Certifications & Licensure
GA State Medical License 2015 - 2027
OH State Medical License 2012 - 2017
MI State Medical License 2009 - 2012
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pyruvate Kinase Deficiency Natural History Study Start of enrollment: 2013 Dec 01
- A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria Start of enrollment: 2018 Feb 22
- Pyruvate Kinase Deficiency Global Longitudinal Registry Start of enrollment: 2018 Apr 23
Publications & Presentations
PubMed
- Eculizumab for Pediatric Hematopoietic Cell Transplant-Associated Thrombotic Microangiopathy: Real-World Response Rates, Predictors of Poor Response, and an Optimal Ti...Michelle L Schoettler, Geoffrey Cheng, Christine S Higham, Christopher C Dvorak, Cassandra Rush
Transplantation and Cellular Therapy. 2026-04-24 - Differential complement activation by alloantibodies in sickle cell hyperhaemolysis syndrome may influence disease course.Mamie M Thant, Jahnavi Gollamudi, Stefanie W Benoit, Satheesh Chonat, Jose A Cancelas
British Journal of Haematology. 2026-04-02 - The emerging role of complement inhibitory approaches in the treatment of acute sickle cell disease complications.Haley Cowan, Ronak Dave, Akshaya Arjunan, Maya Maarouf, Gabrielle Dean
Expert Review of Hematology. 2026-04-01
Abstracts/Posters
- Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Comorbidities and Complications in Adults with Pyruvate Kinase DeficiencySatheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Characterization of the Severe Phenotype of Pyruvate Kinase DeficiencySatheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Rezurock Approved for Chronic Graft-vs-Host DiseaseAugust 4th, 2021
- Ultomiris Approved for Pediatric Patients with Paroxysmal Nocturnal HemoglobinuriaJune 8th, 2021
- Alexion Announces FDA Approval of ULTOMIRIS® (Ravulizumab-Cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)June 7th, 2021
Grant Support
- Complement in the Pathogenesis of Acute Chest SyndromeEMORY UNIVERSITY2024–2029
External Links
- Chonat Labhttps://www.pedsresearch.org/research-group/chonat-laboratory
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
